pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

9,483 catalysts · 3,312 8k filing · 2,032 grant · 1,000 device adverse event · 910 approval · 674 device 510k · 584 earnings

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-08-10: 0 catalysts2026-08-11: 0 catalysts2026-08-12: 0 catalysts2026-08-13: 0 catalysts2026-08-14: 28 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 1 catalyst2026-08-18: 2 catalysts2026-08-19: 3 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 1 catalyst2026-08-27: 1 catalyst2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 1 catalyst2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 2 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 2 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 1 catalyst2026-10-14: 1 catalyst2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 1 catalyst2026-10-20: 2 catalysts2026-10-21: 2 catalysts2026-10-22: 2 catalysts2026-10-23: 1 catalyst2026-10-24: 0 catalysts2026-10-25: 0 catalysts2026-10-26: 1 catalyst2026-10-27: 8 catalysts2026-10-28: 12 catalysts2026-10-29: 21 catalysts2026-10-30: 4 catalysts2026-10-31: 0 catalysts2026-11-01: 0 catalysts2026-11-02: 9 catalysts2026-11-03: 18 catalysts2026-11-04: 22 catalysts2026-11-05: 37 catalysts2026-11-06: 2 catalysts2026-11-07: 0 catalysts2026-11-08: 0 catalysts
view
agendamonth
sort
soonestlatesttypesponsoralpha
from 2026-01-29×clear all
type
  • 8k filing3,312
  • grant2,032
  • device adverse event1,000
  • approval910
  • device 510k674
  • earnings584
device pma
508
  • device recall215
  • phase 2 completion172
  • recall167
  • therapy area
    • Oncology148
    • Infectious Disease46
    • Cardiology37
    • Immunology35
    • Dermatology31
    • Pulmonology22
    • Women's Health19
    • Ophthalmology16
    • Pain15

    Week of Feb 16, 2026

    19
    ›Feb 20, 2026grant176d agoYALE UNIVERSITY — Qdenga Vaccine: Assessment of immunogenicity in a longitudinal cohort study

    AI grant. $251,563. PI: Carolina Lucas

    full page →nih reporter ↗
    ›Feb 20, 2026grant176d agoUNIVERSITY OF VERMONT & ST AGRIC COLLEGE — Differential invasive capacity of Providencia alcalifaciens isolates

    AI grant. $449,393. PI: Leigh Knodler

    full page →nih reporter ↗
    ›Feb 20, 2026grant176d agoBENAROYA RESEARCH INST AT VIRGINIA MASON — Inhibiting CNS resident memory T cells driving neuroinflammation

    AI grant. $489,500. PI: Estelle Bettelli

    full page →nih reporter ↗
    ›Feb 20, 2026grant176d agoSEATTLE CHILDREN'S HOSPITAL — Impact of vaccination and preterm delivery on maternal RSV-specific periphera...Seattle Children's Hospital

    AI grant. $862,347. PI: Whitney Elizabeth Harrington

    full page →nih reporter ↗
    ›Feb 20, 2026grant176d agoCASE WESTERN RESERVE UNIVERSITY — CMV reactivation in the vasculature of people with HIV drives T cell responsesCase Western Reserve University

    AI grant. $233,790. PI: Michael L Freeman

    full page →nih reporter ↗
    ›Feb 20, 2026grant176d agoUNIVERSITY OF CALIFORNIA, SAN DIEGO — Development and validation of S protein as a group A streptococcus vaccineUniversity of California San Diego

    AI grant. $439,375. PI: David J Gonzalez

    full page →nih reporter ↗
    ›Feb 20, 2026grant176d agoUNIVERSITY OF MINNESOTA — Determine how a normal microbial environment protects against autoimmune diab...University of Minnesota

    AI grant. $760,277. PI: Brian T Fife

    full page →nih reporter ↗
    ›Feb 20, 2026grant176d agoBENAROYA RESEARCH INST AT VIRGINIA MASON — Deep analysis of epitope specific CD4+ T cells before the onset of T1D

    AI grant. $2,684,352. PI: Eddie A James

    full page →nih reporter ↗
    ›Feb 20, 2026grant176d agoUNIVERSITY OF COLORADO DENVER — Staphylococcus hominis bacteriocins protect against skin pathogensUniversity of Colorado Denver

    AI grant. $766,730. PI: Richard L Gallo

    full page →nih reporter ↗
    ›Feb 20, 2026grant176d agoNORTHEASTERN UNIVERSITY — Mindful Eating and Mindful Movement for Persons with Type 2 Diabetes Mellitus...Metallomix Inc

    DK grant. $326,208. PI: Neha Pravin Gothe

    full page →nih reporter ↗
    ›Feb 20, 2026grant176d agoJOHNS HOPKINS UNIVERSITY — Tertiary lymphoid structures in chronic rhinosinusitis with nasal polypsJohns Hopkins University

    AI grant. $427,313. PI: ANDREW P LANE

    full page →nih reporter ↗
    ›Feb 20, 2026grant176d agoUNIVERSITY OF MINNESOTA — Defining the Mechanism of Intoxication of the Clostridioides difficile Transf...University of Minnesota

    AI grant. $529,512. PI: Michael J. Sheedlo

    full page →nih reporter ↗
    ›Feb 20, 2026grant176d agoWEILL MEDICAL COLL OF CORNELL UNIV — Conditional M. tuberculosis knockdown mutants in mice with human-like pathology

    AI grant. $211,875. PI: SABINE EHRT

    full page →nih reporter ↗
    ›Feb 21, 2026device 510k175d agoMicro-Tech (Nanjing) Co., Ltd. — Advanced Tissue Resection Device (510k cleared)

    Product code: FDI. Advisory committee: Gastroenterology, Urology. Type: Traditional

    full page →fda device 510k ↗
    ›Feb 21, 2026grant175d agoUNIVERSITY OF CALIFORNIA, SAN DIEGO — Loneliness in Aging with Schizophrenia: Effects of Real-time Positive and Neg...University of California San Diego

    MH grant. $42,596. PI: Miya M Gentry

    full page →nih reporter ↗
    ›Feb 21, 2026grant175d agoUNIVERSITY OF MARYLAND BALTIMORE — Characterizing the novel activity of THC directly at the androgen receptor on...

    DA grant. $48,866. PI: Neema MoinAfshar

    full page →nih reporter ↗
    ›Feb 22, 2026device 510k174d agoOlympus Medical Systems Corp. — Single Use Distal Cover MAJ-2315 (MAJ-2315) (510k cleared)

    Product code: FDT. Advisory committee: Gastroenterology, Urology. Type: Traditional

    full page →fda device 510k ↗
    ›Feb 22, 2026device pma174d agoBiotronik, Inc. — Orsiro Mission Sirolimus Eluting Coronary Stent System; Synsiro Pro Sirolimus Eluting Coronary Stent System (PMA supplement)OrphAI Therapeutics Inc

    Supplement type: 30-Day Notice. Product code: NIQ. Advisory committee: CV. Decision: OK30

    full page →fda device pma ↗
    ›Feb 22, 2026grant174d agoUNIVERSITY OF MICHIGAN AT ANN ARBOR — Identifying Global Rejuvenation Mechanisms in Tissues that Reverses Age-Relat...

    AG grant. $43,588. PI: Angelo Anacleto

    full page →nih reporter ↗

    Week of Feb 23, 2026

    31
    ›Feb 23, 2026approval173d agoDUPIXENT (DUPILUMAB) — FDA approvaldupilumab

    Sponsor: REGENERON PHARMACEUTICALS. Form: INJECTABLE. Route: INJECTION

    full page →dupilumab →fda approvals ↗
    ›Feb 23, 2026approval
    ← prev
    page 30 of 190
    next →
    173d ago
    EFINACONAZOLE — FDA approvalEFINACONAZOLE

    Sponsor: ALEMBIC. Form: SOLUTION. Route: TOPICAL

    full page →EFINACONAZOLE →fda approvals ↗
    ›Feb 23, 2026approval173d agoBRIVARACETAM — FDA approvalBRIVARACETAM

    Sponsor: LUPIN. Form: SOLUTION. Route: ORAL

    full page →BRIVARACETAM →fda approvals ↗
    ›Feb 23, 2026approval173d agoBRIVARACETAM — FDA approvalUCB SA

    Sponsor: HAINAN POLY. Form: SOLUTION. Route: INTRAVENOUS

    full page →fda approvals ↗
    ›Feb 23, 2026approval173d agoBRIVARACETAM — FDA approvalUCB SA

    Sponsor: REGCON HOLDINGS. Form: SOLUTION. Route: ORAL

    full page →fda approvals ↗
    ›Feb 23, 2026approval173d agoBRIVARACETAM — FDA approvalCentaur Pharmaceuticals Pvt Ltd

    Sponsor: CENTAUR PHARMS PVT. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Feb 23, 2026approval173d agoMYCOPHENOLATE MOFETIL — FDA approvalMYCOPHENOLATE MOFETIL

    Sponsor: AMNEAL. Form: FOR SUSPENSION. Route: ORAL

    full page →MYCOPHENOLATE MOFETIL →fda approvals ↗
    ›Feb 23, 2026approval173d agoBRIVARACETAM — FDA approvalBRIVARACETAM

    Sponsor: APOTEX. Form: TABLET. Route: ORAL

    full page →BRIVARACETAM →fda approvals ↗
    ›Feb 23, 2026approval173d agoSODIUM PHOSPHATES (SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE) — FDA approval

    Sponsor: CAPLIN. Form: SOLUTION. Route: INTRAVENOUS

    full page →fda approvals ↗
    ›Feb 23, 2026approval173d agoBRIVARACETAM — FDA approvalBRIVARACETAM

    Sponsor: MICRO LABS. Form: SOLUTION. Route: INTRAVENOUS

    full page →BRIVARACETAM →fda approvals ↗
    ›Feb 23, 2026approval173d agoBRIVARACETAM — FDA approvalBRIVARACETAM

    Sponsor: MSN. Form: SOLUTION. Route: INTRAVENOUS

    full page →BRIVARACETAM →fda approvals ↗
    ›Feb 23, 2026approval173d agoIPRATROPIUM BROMIDE — FDA approvalArmstrong Pharmaceuticals Inc

    Sponsor: ARMSTRONG PHARMS. Form: AEROSOL, METERED. Route: INHALATION

    full page →fda approvals ↗
    ›Feb 23, 2026approval173d agoTOPIRAMATE — FDA approvalLP Pharmaceutical (Xiamen) Co Ltd

    Sponsor: SUN PHARM INDS LTD. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Feb 23, 2026approval173d agoTOPIRAMATE — FDA approvalLP Pharmaceutical (Xiamen) Co Ltd

    Sponsor: SUN PHARM INDS LTD. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Feb 23, 2026approval173d agoTOPIRAMATE — FDA approvalLP Pharmaceutical (Xiamen) Co Ltd

    Sponsor: SUN PHARM INDS LTD. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Feb 23, 2026approval173d agoTOPIRAMATE — FDA approvalLP Pharmaceutical (Xiamen) Co Ltd

    Sponsor: SUN PHARM INDS LTD. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Feb 23, 2026approval173d agoTOPIRAMATE — FDA approvalLP Pharmaceutical (Xiamen) Co Ltd

    Sponsor: SUN PHARM INDS LTD. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Feb 23, 2026approval173d agoTOPIRAMATE — FDA approvalLP Pharmaceutical (Xiamen) Co Ltd

    Sponsor: SUN PHARM INDS LTD. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Feb 23, 2026approval173d agoTOPIRAMATE — FDA approvalLP Pharmaceutical (Xiamen) Co Ltd

    Sponsor: SUN PHARM INDS LTD. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Feb 23, 2026approval173d agoTOPIRAMATE — FDA approvalLP Pharmaceutical (Xiamen) Co Ltd

    Sponsor: SUN PHARM INDS LTD. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Feb 23, 2026approval173d agoPREGABALIN — FDA approvalViatris Inc

    Sponsor: ALKEM LABS LTD. Form: SOLUTION. Route: ORAL

    full page →fda approvals ↗
    ›Feb 23, 2026approval173d agoBRIVARACETAM — FDA approvalUCB SA

    Sponsor: ZHEJIANG POLY PHARM. Form: SOLUTION. Route: ORAL

    full page →fda approvals ↗
    ›Feb 23, 2026approval173d agoDILTIAZEM HYDROCHLORIDE — FDA approvalZydus Therapeutics Inc

    Sponsor: ZYDUS PHARMS. Form: CAPSULE, EXTENDED RELEASE. Route: ORAL

    full page →fda approvals ↗
    ›Feb 23, 2026approval173d agoDILTIAZEM HYDROCHLORIDE — FDA approvalZydus Therapeutics Inc

    Sponsor: ZYDUS PHARMS. Form: CAPSULE, EXTENDED RELEASE. Route: ORAL

    full page →fda approvals ↗
    ›Feb 23, 2026approval173d agoBRIVARACETAM — FDA approvalUCB SA

    Sponsor: ALKEM LABS LTD. Form: SOLUTION. Route: ORAL

    full page →fda approvals ↗
    ›Feb 23, 2026approval173d agoSUSTOL (GRANISETRON) — FDA approvalgranisetron ER

    Sponsor: HERON THERAPS INC. Form: INJECTABLE. Route: SUBCUTANEOUS

    full page →granisetron ER →fda approvals ↗
    ›Feb 23, 2026approval173d agoPREGABALIN — FDA approvalPREGABALIN

    Sponsor: LUPIN LTD. Form: CAPSULE. Route: ORAL

    full page →PREGABALIN →fda approvals ↗
    ›Feb 23, 2026approval173d agoPREGABALIN — FDA approvalPREGABALIN

    Sponsor: LUPIN LTD. Form: CAPSULE. Route: ORAL

    full page →PREGABALIN →fda approvals ↗
    ›Feb 23, 2026approval173d agoLOARGYS (PEGZILARGINASE-NBLN) — FDA approvalpegzilarginase

    Sponsor: IMMEDICA PHARMA AB. Form: Injectable. Route: Injection

    full page →pegzilarginase →fda approvals ↗
    ›Feb 23, 2026device 510k173d agoPoskom Co., Ltd. — AirRay-mini 80A, AirRay-mini 90A, AirRay-mini 80F, AirRay-mini 90F (AirRay-mini) (510k cleared)

    Product code: IZL. Advisory committee: Radiology. Type: Traditional

    full page →fda device 510k ↗
    ›Feb 23, 2026device 510k173d agoVita Zahnfabrik H. Rauter GmbH & Co. Kg. — VITA VMLC Primer (510k cleared)

    Product code: KLE. Advisory committee: Dental. Type: Traditional

    full page →fda device 510k ↗
    $REGN802.63-0.41%
    $HRTX0.5114+3.06%
    $VTRS16.14+0.59%
    $AMRX17.27-2.21%